SB

Samsara BioCapital Portfolio holdings

AUM $489M
1-Year Est. Return 135.25%
This Quarter Est. Return
1 Year Est. Return
+135.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$497M
AUM Growth
+$496M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
50
New
Increased
Reduced
Closed

Top Sells

1 +$8.57M
2 +$6.82M
3 +$2.22M
4
BCEL
Atreca, Inc. Class A Common Stock
BCEL
+$1.2M
5
ATXS icon
Astria Therapeutics
ATXS
+$434K

Sector Composition

1 Healthcare 97.77%
2 Financials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$66.9M 12.35%
2,034,703
2
$49.2M 9.08%
3,168,388
3
$43.9M 8.09%
1,565,529
+147,000
4
$39M 7.19%
+77,701
5
$38.1M 7.03%
1,675,579
6
$25.8M 4.75%
1,022,612
-340,000
7
$24.3M 4.48%
+36,873
8
$16.8M 3.1%
146,259
9
$14.8M 2.73%
640,688
+237,000
10
$14.8M 2.72%
218,920
11
$14.7M 2.7%
2,372,476
12
$12.5M 2.3%
169,852
-92,720
13
$10.9M 2.02%
+497,555
14
$9.39M 1.73%
+826,422
15
$9.29M 1.71%
1,111,112
16
$8.72M 1.61%
95,318
17
$7.69M 1.42%
+831,625
18
$7M 1.29%
35,349
19
$6.08M 1.12%
396,835
-78,108
20
$5.56M 1.03%
500,000
21
$5.47M 1.01%
30,160
22
$5.46M 1.01%
764,403
-309,882
23
$4.99M 0.92%
507,041
+501,818
24
$4.96M 0.92%
549,250
+115,000
25
$4.87M 0.9%
166,250